XDH and hyperuricemia: Additionally, scopoletin administered either by intraperitoneal injection or by oral gavage of scopoletin-loaded micelles was shown to correct hyperuricemia in mice through two separate mechanisms, namely inhibiting hepatic XO activity and enhancing uric acid excretion by the kidney (201, 202).